Protective effect of Cl-amidine against CLP-induced lethal septic shock in mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhao, Ting ^a   Pan, Baihong ^a   Alam, Hasan B ^a   Liu, Baoling ^a   Bronson, Roderick T ^b   Deng, Qiufang ^a   Wu, Erxi ^c   Li, Yongqing ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; N-ALPHA-BENZOYL-N5-(2-CHLORO-1-IMINOETHYL)-L-ORNITHINE AMIDE; ORNITHINE;

ANALOGS AND DERIVATIVES; ANIMAL; ATROPHY; BONE MARROW; C57BL MOUSE; CECUM; CHEMICALLY INDUCED; DRUG EFFECT; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; LIVER; MALE; METABOLISM; MICROBIOLOGY; PATHOLOGY; SEPTIC SHOCK; SURVIVAL ANALYSIS; THYMUS;

ANIMALS; ATROPHY; BONE MARROW; CECUM; CYTOKINES; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE, INBRED C57BL; ORNITHINE; SHOCK, SEPTIC; SURVIVAL ANALYSIS; THYMUS GLAND;

EID: 84994807614     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36696     Document Type: Article

References (27)

1. Boomer, J. S., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA: the journal of the American Medical Association 306, 2594-2605, doi: 10.1001/jama.2011.1829 (2011
2. Wenzel, R. P., & Edmond, M. B. Septic shock-evaluating another failed treatment. The New England journal of medicine 366, 2122-2124, doi: 10.1056/NEJMe1203412 (2012
3. Slack, J. L., Causey, C. P., & Thompson, P. R. Protein arginine deiminase 4: a target for an epigenetic cancer therapy. Cellular and Molecular Life Sciences 68, 709-720 (2011
4. Kearney, P. L., et al. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. Biochemistry 44, 10570-10582 (2005
5. Subramanian, V., et al. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors. Journal of medicinal chemistry 58, 1337-1344, doi: 10.1021/jm501636x (2015
6. Wang, S., et al. ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells. Molecular cancer therapeutics 14, 877-888, doi: 10.1158/1535-7163.MCT-14-1093-T (2015
7. Chumanevich, A. A., et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. American journal of physiology. Gastrointestinal and liver physiology 300, G929-G938, doi: 10.1152/ajpgi.00435.2010 (2011
8. Schellekens, G. A., De Jong, B. A., van Den Hoogen, F. H., van De Putte, L. B., & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. The Journal of clinical investigation 101, 273-281, doi: 10.1172/JCI1316 (1998
9. Chen, C. C., et al. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population. Clinical immunology 126, 165-171, doi: 10.1016/j.clim.2007.09.001 (2008
10. Moscarello, M. A., Mastronardi, F. G., & Wood, D. D. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochemical research 32, 251-256, doi: 10.1007/s11064-006-9144-5 (2007
11. Ishigami, A., et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. Journal of neuroscience research 80, 120-128, doi: 10.1002/jnr.20431 (2005
12. Anzilotti, C., Pratesi, F., Tommasi, C., & Migliorini, P. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmunity reviews 9, 158-160, doi: 10.1016/j.autrev.2009.06.002 (2010
13. Chang, X., & Han, J. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Molecular carcinogenesis 45, 183-196, doi: 10.1002/mc.20169 (2006
14. Jones, J. E., Causey, C. P., Knuckley, B., Slack-Noyes, J. L., & Thompson, P. R. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. Current opinion in drug discovery, & development 12, 616-627 (2009
15. Li, Y., et al. Citrullinated histone H3: A novel target for the treatment of sepsis. Surgery 156, 229-234, doi: 10.1016/j.surg.2014.04.009 (2014
16. Zhao, E., et al. Bone marrow and the control of immunity. Cellular, & molecular immunology 9, 11-19, doi: 10.1038/cmi.2011.47 (2012
17. Annane, D. The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update. Front Endocrinol (Lausanne) 7, 70, doi: 10.3389/fendo.2016.00070 (2016
18. Zhao, T., et al. Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model. Surgery 156, 235-242, doi: 10.1016/j.surg.2014.03.033 (2014
19. Wang, H., & Ma, S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 26, 711-715, doi: 10.1016/j.ajem.2007.10.031 (2008
20. Liu, Z., et al. Synergistic effects of hypertonic saline and valproic acid in a lethal rat two-hit model. The journal of trauma and acute care surgery 74, 991-997; discussion 997-998, doi: 10.1097/TA.0b013e31828583e3 (2013
21. Cheng, X., et al. Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model. The Journal of surgical research 197, 39-44, doi: 10.1016/j.jss.2015.02.070 (2015
22. Zhao, T., et al. Selective Inhibition of SIRT2 Improves Outcomes in a Lethal Septic Model. Current molecular medicine 15, 634-641 (2015
23. Zhao, T., et al. Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsis. The journal of trauma and acute care surgery 77, 913-919; discussion 919, doi: 10.1097/TA.0000000000000347 (2014
24. Chong, W., et al. Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages. The Journal of surgical research 178, 851-859, doi: 10.1016/j.jss.2012.07.023 (2012
25. Zhao, T., et al. Novel pharmacologic treatment attenuates septic shock and improves long-term survival. Surgery 154, 206-213, doi: 10.1016/j.surg.2013.04.003 (2013
26. Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nature protocols 4, 31-36, doi: 10.1038/nprot.2008.214 (2009
27. Zhao, T., et al. Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model. The journal of trauma and acute care surgery 80, 34-40; discussion 40-31, doi: 10.1097/TA.0000000000000897 (2016